Leading science, pioneering therapies

CRM Publications

Found 4 results
Filters: Keyword is Feasibility Studies  [Clear All Filters]
2012
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du M-Q, Luan S-L, Altmann DR, Thompson AJ et al..  2012.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.Lancet Neurol. 11(2):150-6.
2011
Connick P, Kolappan M, Patani R, Scott MA, Crawley C, He X-L, Richardson K, Barber K, Webber DJ, Wheeler-Kingshott CAM et al..  2011.  The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.Trials. 12:62.
2008
Lorenzini S, Isidori A, Catani L, Gramenzi A, Talarico S, Bonifazi F, Giudice V, Conte R, Baccarani M, Bernardi M et al..  2008.  Stem cell mobilization and collection in patients with liver cirrhosis.Aliment Pharmacol Ther. 27(10):932-9.
1996
Zeiger MA, Takiyama Y, Bishop JO, Ellison AR, Saji M, Levine MA.  1996.  Adenoviral infection of thyroid cells: a rationale for gene therapy for metastatic thyroid carcinoma.Surgery. 120(6):921-5.